文献リスト

1) Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular con-duction delay. J Am Coll Cardiol. 2002; 39: 2026-33

2) Gras D, Leclercq C, Tang A, et al. Cardiac resynchronization therapy in advanced heat failure the multicenter InSync clinical study. Eur J Heart Failure. 2002; 4: 311-20

3) Cazeau S, Leclerq C, Lavergene T, et al. Multisite stimulation in biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001; 344: 873-80

4) Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the multisite stimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002; 40: 111-8

5) Bristow MR, Saxon LA, Boehmer J, et al. Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50

6) Abraham WT, Fisher WG, Smith AL, et al. MIRACLE study group. Multicenter InSync Randomised Clinical Evaluation. Cardiac resynchronization in chronic geart failure, N Engl J Med. 2002; 346: 1845-53

7) Bradley DJ, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003; 289: 730

8) Young JB, Abrham WT, Smith AL, et al. Safety and efficacy of combined cardiac rsynchronization therapy and implantable cardioversion defibrillation in patients with advanced chronic heart failure. The Multicenter InSync ICD Randamized Clinical Evaluation (MIRACLE ICD) trial. JAMA. 2003; 289: 2685-94

9) Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randamised controlled trials. Eur Heart J. 2006; 27: 2682-8

10) Lozano I, Bocchiardo M, Achtelik M, et al. VENTAK CHF/CONTAK CD Investigators study group. Impact of biventricular pacing on mortality in a randamised crossover study of patients with heart failure and ventricular arrhythymia. Pacing Clin Electrophysiol. 2000; 23: 1711-2

11) Cleland J, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352: 1539-49

12) A Report of the American College Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA 2005. Guideline update for the diagnosis and management of chronic heart failure in the adult: Summary article. Am J Coll Cardiol. 2005; 46: 1116-43

13) Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 guideline for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline: developed in collaboration with the International Society for HBeart and Lung Transplantation. Circulation. 2009; 119: e391-479

14) Epstein aE, DiMArco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guideline for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/american Heart Association Task Force on Practice Guideline (Writing Committee to Revice the ACC/AHA/NSPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008; 117: e350-408

15) Swedberg K, Cleland J, Dargie H, et al. Task force for the diagnosis and treatment of chronic heart failure on the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005). Eur Heart J. 2005; 26: 1115-40

16) Buckingham TA, Candinas R, Duru F, et al. Acute hemodynamic effects of alternate and combined site pacing in patients after cardiac surgery. PACE. 1999; 22: 887-93

17) Zimmerman FJ, Starr JP, Koenig PR, et al. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg. 2003; 75: 1175-80

18) Strieper M, Karpawich P, Frias P, et al. Initial expreience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. Am J Cardiol. 2004; 94: 1352-4

19) Janousek J, Tomek V, Chaloupecky V, et al. Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol. 2004; 44: 1927-31

20) Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: An initernational multicenter study. J Am Coll Cardiol. 2005; 46: 2277-83

21) Khairy P, Fournier A, Thibault B, et al. Cardiac resynchronization therapy in congenital heart disease. Int J Cardiol. 2006; 109: 160-8

22) van Beek E, Backx A, Singh S. Cardiac resynchronization as therapy for congestive cardiac failure in children dependent on chronic cardiac pacing. Cardiol Young. 2006; 16: 187-9

23) Moak JP, Hasbani K, RamwellC, et al. Dilated cardiomyopathy following right ventricular pacing for AV block in young patients: Resolution after upgrading to biventricular pacing systems. J Cardiovasc Electrophysiol. 2006; 17: 1068-71

24) Janousek J, Grollmuss O, Abdul-Khaliq H, et al. For the Working Group for Cardiac Dysrhythmias and Electrophysiology of the AEPC. Cardiac resynchronization therapy in congenital and pediatric heart disease: A Retrospective European Multicenter Study (abstract). Cardiol Young. 2006; 16: 2-3

25) Janousek J, Gebauer RA, Abdul-pKhaliq H, et al. Cardiac resynchronization therapy in pediatric and congenital heart disesase: differential effects in various anatomic and functional substrates. Heart. 2009; 95: 1165-71

26) Cecchin F, Frangini PA, Brown DW, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009; 20: 58-65

27) Dubin AM, Rosenthal DN. Right ventricular resynchronization: moving beyond proof of concept. Heart rhythm. 2009; 6: 857-9

28) Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Review. Circulation. 2003; 108: 2596-603

29) McAllister FA, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007; 297: 2502-14

30) Bax JJ, Gorcsan JIII. Echocardiography and noninvasive imaging in cardiac resynchronization therapy. J Am Coll Cadiol. 2009; 53: 1933-43

31) Hawkins NM, Petrie MC, Burgess MI, et al. Selecting patients for cardiac resynchronization therapy. J Am Coll Cardiol. 2009; 53: 1944-59

32) Yu CM, Chan YS, Zhang Q, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and cexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006; 48: 2251-7

33) Bleeker GB, Holman ER, Steendijk P, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol. 2006; 48: 2243-50

34) Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT(PROSPECT) trial. Circulatoin. 2008; 117: 2608-16

35) Saul JP, Epstein AE, Silka MJ, et al. Heart Rhythm Society/Pediatric and Congenital Electrophysiology Society Clinical Competency Statement: training pathways for implantation of cardioverter-defibrillators and cardiac resynchronization therapy devices in pediatric and congenital heart patients. Heart Rhythm. 2008; 5: 926-33

36) Sonne C, Sugeng L, Takeuchi M, et al. Real-time transthoracic three dimensional echocardiography; normal reference data for left ventricular dysynchrony in adolescents. J Am Soc Echocardiogr. 2009; 22: 933-8

37) Ypenburg C, van Bommel RJ, Delgado V, et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol. 2008; 52: 1402-9

38) Suffoletto MS, Dohi K, Canesson M, et al. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation. 2006; 113: 960-8

39) Ansalone G, Giannantoni P, Ricci R, et al. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol. 2002; 39: 489-99

40) Becker M, Franke A, Breithardt OE, et al. Impact of left ventricular lead position on the efficacy of cardiac resynchronization therapy. A two-dimensional strain echocardiography study. Heart. 2007; 93: 1197-203

41) Murphy RT, Sigurdsson G, Mulanmalla S, et al. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol. 2006; 97: 1615-21

42) Carasso S, Rakowski H, Witter KK, et al. Left ventricular strain patterns in dilated cardiomyopathy predict response to cardiac resynchronization therapy: timing is not everything. J Am Soc Echocardiogr. 2009; 22: 242-50

43) Silva JN, Ghosh S, Bowman TM, et al. Cardiac resynchronization therapy in pediatric congenital heart disease: insights from noninvasive electrocardiographic imaging. Heart rhythm. 2009; 6: 1178-85

44) Karpawich PP. Technical aspects of pacing in adult and pediatric congenital heart disease. PACE. 2008; 31: S28-31

45) 安河内 聰. 小児の難治性心不全に対する心臓再同期治療. 心臓. 2009; 41: 886-93

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp